Médicos para Meduloblastoma no exterior — Página 2

O Dr. Yildiz publicou extensivamente sobre tumores neuroendócrinos e cancros raros, com investigações apresentadas em revistas médicas internacionais.

• Especializar-se em tumores neuroendócrinos e casos de cancro raros
• Publicar mais de 17 artigos revistos por pares em oncologia
• Trabalhar no Hospital Universitário Medipol Mega
• Ter experiência no diagnóstico e tratamento de casos oncológicos complexos

O Professor Shlomi Constantini é especialista em neurocirurgia pediátrica, especializado em tumores cerebrais e da coluna vertebral no Sourasky Medical Center.

• Mais de 15 anos de experiência em neurocirurgia
• Formado em microneurocirurgia e neuroendoscopia avançada
• Vencedor do prêmio Mahaly de Melhor Pesquisa Clínica da AANS
• Especializado em intervenções microcirúrgicas e reconstrutivas
• Membro de múltiplas sociedades neurocirúrgicas internacionais

O Dr. Dror Levin é especializado em cancros pediátricos, coordenando o tratamento de sarcomas no Sourasky Medical Center – a principal instalação de Israel.

• Diretor de hematologia-oncologia pediátrica no Sourasky
• Formado no Rizzoli Orthopaedic Institute – líder global em cancro ósseo
• Membro da ISPHO (Sociedade de Hematologia e Oncologia Pediátrica de Israel)
• Especializar-se em distúrbios sanguíneos e problemas de coagulação em crianças

O Prof. Dr. Wolfgang Köstler é um especialista de renome em terapias oncológicas direcionadas, com mais de duas décadas de experiência em oncologia médica.

• Especializar-se em cancro da mama e neoplasias ginecológicas
• Professor Associado na Universidade Médica de Viena
• Subchefe da Divisão Clínica de Oncologia
• Focar-se na terapia oncológica sistémica individualizada e imunoterapia

A Dra. Inta Jaunalksne é especialista em viroterapia – uma abordagem de ponta em imunologia com mais de 30 anos de experiência.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com residência em Medicina Interna
• Focar em tratamentos imunológicos inovadores

O Prof. Adjunto Nail Paksoy traz conhecimentos especializados em meduloblastoma, resultantes da sua residência no Instituto de Oncologia da Universidade de Istambul e da sua função atual no Hospital Medipol Bahçelievler.

• Certificado pela ESMO em Oncologia Médica
• Participar em 8 ensaios clínicos internacionais para cancros avançados
• Publicar vários estudos revistos por pares sobre tratamentos de cancros raros
• Concluir uma formação de dupla especialização em Oncologia Médica e Alergologia-Imunologia

Especialista em meduloblastoma com vasta formação em oncologia médica na Universidade Akdeniz.

• Certificado em oncologia médica desde 2018
• Mais de 15 anos de experiência em oncologia
• Trabalha no Complexo Hospitalar Medical Park Antalya

O Prof. Deniz Konya é especialista em tumores espinhais no Hospital Medical Park Göztepe, com mais de 15 anos de experiência em neurocirurgia.

• Formado no Brigham and Women's Hospital da Harvard Medical School
• Membro da diretoria da Sociedade Turca de Coluna e de grupos internacionais de coluna
• Publicou 47 artigos revisados por pares sobre tratamentos da coluna vertebral
• Realizar procedimentos avançados para fraturas e deformidades na coluna

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

O Dr. Sergei Postovskiy é Chefe Adjunto do Departamento de Hematologia Pediátrica do Rambam Medical Center.

• Especialização no tratamento de crianças com cancro, incluindo tumores cerebrais
• Sediado no Rambam Medical Center, um centro líder em oncologia pediátrica
• Envolvimento direto na gestão de casos pediátricos complexos

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

O Dr. Do Hyun Nam é um neurocirurgião de renome na Coreia do Sul, especializado na remoção de tumores cerebrais e cirurgias endoscópicas no Samsung Medical Center.

• Ser especialista no tratamento de pacientes pediátricos e adultos
• Especializar-se em técnicas de endoscopia e radiocirurgia
• Focar-se em neoplasias cerebrais benignas e malignas